Integrated LC-MS Strategies for Drug Discovery and Clinical Bioanalysis
Pharmaceutical development groups frequently maintain entirely separate analytical pipelines, instruments, and software configurations to process small molecules and large biologics. An integrated liquid chromatography–mass spectrometry infrastructure allows a single laboratory to support both modalities from initial discovery through clinical trials.
This eBook lays out complete integrated bioanalytical workflows designed to remove sample preparation bottlenecks and satisfy data integrity regulations.
Download this eBook to see how:
- Unified separation systems process diverse sample types without requiring hardware reconfigurations
- High-resolution mass spectrometry captures both qualitative structural profiles and quantitative values simultaneously
- Compliance-ready software architectures streamline sample tracking and data reporting for regulatory submissions